NEW YORK ─ Boston-based Binx Health will provide access to sexually transmitted infection testing for US college students as part of an expanded agreement with health insurer Wellfleet, the companies announced Wednesday.
Financial and other terms of the expanded agreement were not disclosed.
In October 2020, Binx and Springfield, Massachusetts-based Wellfleet, a Berkshire Hathaway company, had announced an agreement that enabled college students to do at-home and in-dorm sample collection for COVID-19 testing using Binx's enterprise solutions for population health screening.
In March, the US Food and Drug Administration granted a CLIA waiver to Binx for its io CT/NG Assay, which runs on the firm's PCR-based io instrument and detects and distinguishes Chlamydia trachomatis and Neisseria gonorrhoeae in approximately 30 minutes using either female vaginal swab or male urine specimens.
In February, Binx announced a partnership with McKesson for the sale and distribution of the Binx io testing platform in the US.